Multiple Myeloma is a serious but treatable form of blood cancer that affects plasma cells in the bone marrow. A diagnosis can feel overwhelming for patients and families. However, advances in chemotherapy, targeted therapy, immunotherapy, and Bone Marrow Transplant (BMT) have significantly improved survival rates and quality of life.
In this detailed guide, we will explain:
- What Multiple Myeloma is
- Symptoms and stages
- Latest treatment options
- When a bone marrow transplant is needed
- Why India is a leading destination for Multiple Myeloma treatment
- Cost of treatment in India
- FAQs for patients and medical tourists
What is Multiple Myeloma?
Multiple Myeloma is a cancer of plasma cells, which are white blood cells responsible for producing antibodies to fight infections. These cells are found inside the bone marrow.
When plasma cells become cancerous, they multiply uncontrollably and crowd out healthy blood cells. This weakens immunity, damages bones, and affects kidney function.
How Multiple Myeloma Affects the Body
Healthy plasma cells protect us from infections. In Multiple Myeloma:
- Abnormal plasma cells produce defective antibodies (M-protein).
- Bones become weak and prone to fractures.
- Red blood cell production decreases, causing anaemia.
- Kidney damage may occur due to excess protein buildup.
Doctors often refer to the CRAB symptoms:
- C – High Calcium levels
- R – Renal (kidney) problems
- A – Anaemia
- B – Bone damage
Common Symptoms of Multiple Myeloma
- Persistent bone pain (especially spine or ribs)
- Frequent infections
- Fatigue and weakness
- Unexplained weight loss
- Numbness or tingling in legs
- Excessive thirst (due to high calcium)
Early detection improves treatment outcomes significantly.
Stages of Multiple Myeloma
Doctors classify the disease using the Revised International Staging System (R-ISS):
- Stage I – Early stage, low-risk
- Stage II – Intermediate risk
- Stage III – Advanced stage, aggressive disease
Genetic markers also play an important role in predicting prognosis.
Treatment Options for Multiple Myeloma
Treatment depends on stage, age, overall health, and genetic risk factors.
- Chemotherapy
High-dose anti-cancer drugs destroy rapidly dividing myeloma cells.
Commonly used regimens include combinations of:
- Bortezomib
- Cyclophosphamide
- Dexamethasone
- Targeted Therapy
Targeted drugs attack specific proteins in myeloma cells.
Examples include:
- Proteasome inhibitors
- Monoclonal antibodies
- Immunomodulatory drugs
These therapies are more precise and often have fewer side effects than traditional chemotherapy.
- Immunotherapy
Immunotherapy strengthens the body’s immune system to fight cancer.
Advanced treatments include:
- CAR-T Cell Therapy
- Bispecific antibodies
- Bone Marrow Transplant (BMT) for Multiple Myeloma
A Bone Marrow Transplant, also called Hematopoietic Stem Cell Transplant, is one of the most effective treatments for eligible patients.
What Happens During BMT?
- High-dose chemotherapy destroys cancer cells.
- Healthy stem cells are infused.
- The body rebuilds new, healthy bone marrow.
Types of BMT for Multiple Myeloma
Autologous BMT
- Uses the patient’s own stem cells
- Most common type for Multiple Myeloma
- Lower risk of rejection
Allogeneic BMT
- Uses donor stem cells
- Less common
- Higher risk but stronger anti-cancer effect
When is a Bone Marrow Transplant Recommended?
Doctors may recommend BMT when:
- Patient is under 65–70 years and medically fit
- Disease responds to initial chemotherapy
- Relapse occurs after the first treatment
- High-risk genetic features are present
BMT is not usually the first step, but part of a comprehensive treatment plan.
Multiple Myeloma Treatment in India
India has become a global hub for advanced cancer treatment, especially for blood cancers and bone marrow transplants.
Why Choose India?
- Advanced Cancer Centres
Cities like:
- Delhi
- Mumbai
- Chennai
- Bangalore
have internationally accredited cancer hospitals with specialised BMT units.
- Experienced Haematologists
Indian oncologists perform thousands of successful Bone Marrow Transplants every year, with outcomes comparable to those in Western countries.
- Affordable Treatment Cost
| Treatment | Cost in the USA | Cost in India |
| Autologous BMT | $150,000–$250,000 | $18,000–$30,000 |
| Chemotherapy (per cycle) | $10,000+ | $1,000–$2,500 |
| Targeted Therapy | Very Expensive | 60–70% lower |
This cost difference makes India highly attractive for international patients from Africa, the Middle East, and Southeast Asia.
- Shorter Waiting Time
Unlike many Western countries, patients can begin treatment within days.
Preparation for Bone Marrow Transplant
Before transplant:
- Complete blood work
- Heart and lung evaluation
- Stem cell collection
- Infection screening
- Counselling and consent
Risks of Bone Marrow Transplant
Although life-saving, BMT carries risks:
- Severe infections
- Organ toxicity
- Infertility
- Relapse
- Graft-versus-host disease (in donor transplant)
Doctors carefully evaluate whether benefits outweigh risks.
Recovery After Multiple Myeloma Treatment
Recovery may take 3–6 months.
Patients require:
- Regular blood tests
- Infection prevention
- Nutritious diet
- Emotional support
- Vaccinations
With proper follow-up, many patients return to normal life.
Real Patient Example
A 48-year-old patient from Kenya diagnosed with Stage II Multiple Myeloma underwent chemotherapy followed by Autologous BMT in Delhi. Within 4 months, he achieved complete remission and resumed work.
Such success stories highlight why India is becoming a preferred destination for international medical tourism.
Frequently Asked Questions (FAQs)
What is the survival rate for Multiple Myeloma?
With modern treatment and BMT, many patients live 8–15 years or longer, depending on stage and genetics.
Is Multiple Myeloma curable?
It is generally considered treatable but not fully curable. Long-term remission is possible.
How long does BMT take?
Hospital stay is usually 2–3 weeks. Full recovery takes several months.
Can older patients undergo a transplant?
Reduced-intensity transplant may be possible after medical evaluation.
Can international patients travel to India for treatment?
Yes. India offers medical visas, international patient coordinators, and affordable packages.
Conclusion
Multiple Myeloma treatment has evolved significantly over the last decade. With chemotherapy, targeted therapy, immunotherapy, and Bone Marrow Transplant, patients today have better survival rates and improved quality of life.
India offers:
- World-class hospitals
- Expert haematologists
- Affordable treatment
- Advanced transplant facilities
If you or your loved one is facing Multiple Myeloma, early diagnosis and personalised treatment planning are crucial.
